Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Integer Holdings Co. stock logo
ITGR
Integer
$124.25
-4.4%
$128.00
$79.68
$133.53
$4.16B1.08312,152 shs285,519 shs
LivaNova PLC stock logo
LIVN
LivaNova
$51.62
+0.5%
$50.93
$42.75
$64.47
$2.80B1622,489 shs522,997 shs
Masimo Co. stock logo
MASI
Masimo
$144.01
+0.8%
$128.51
$75.36
$153.93
$7.66B0.99673,875 shs655,800 shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$81.97
+0.1%
$144.20
$36.42
$177.37
$2.73B1.99938,018 shs2.32 million shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Integer Holdings Co. stock logo
ITGR
Integer
-0.10%+2.70%+0.08%+11.93%+60.08%
LivaNova PLC stock logo
LIVN
LivaNova
-3.08%-3.13%-2.28%+6.25%+4.67%
Masimo Co. stock logo
MASI
Masimo
+1.30%+0.63%+7.17%+33.13%+76.12%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-7.44%-30.96%-47.82%-45.93%+118.57%
This Bull Market Indicator called NVDA at $116 (Ad)

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Integer Holdings Co. stock logo
ITGR
Integer
3.747 of 5 stars
3.43.00.00.01.82.52.5
LivaNova PLC stock logo
LIVN
LivaNova
4.0325 of 5 stars
4.53.00.00.02.11.71.9
Masimo Co. stock logo
MASI
Masimo
3.2606 of 5 stars
1.31.00.04.21.91.72.5
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
3.8234 of 5 stars
4.51.00.00.02.22.51.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Integer Holdings Co. stock logo
ITGR
Integer
2.88
Moderate Buy$139.7512.47% Upside
LivaNova PLC stock logo
LIVN
LivaNova
3.00
Buy$69.1733.99% Upside
Masimo Co. stock logo
MASI
Masimo
2.57
Moderate Buy$145.330.92% Upside
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
3.00
Buy$144.8076.65% Upside

Current Analyst Ratings

Latest TMDX, MASI, ITGR, and LIVN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/31/2024
LivaNova PLC stock logo
LIVN
LivaNova
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$80.00 ➝ $70.00
10/31/2024
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$75.00 ➝ $75.00
10/31/2024
LivaNova PLC stock logo
LIVN
LivaNova
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$66.00 ➝ $72.00
10/29/2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$180.00 ➝ $180.00
10/29/2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$173.00 ➝ $116.00
10/29/2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$200.00 ➝ $150.00
10/29/2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$169.00 ➝ $109.00
10/29/2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$200.00 ➝ $125.00
10/29/2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$208.00 ➝ $109.00
10/25/2024
Integer Holdings Co. stock logo
ITGR
Integer
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$125.00 ➝ $140.00
10/25/2024
Integer Holdings Co. stock logo
ITGR
Integer
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$150.00 ➝ $147.00
(Data available from 10/31/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Integer Holdings Co. stock logo
ITGR
Integer
$1.71B2.43$7.86 per share15.81$45.58 per share2.73
LivaNova PLC stock logo
LIVN
LivaNova
$1.21B2.31$4.27 per share12.10$23.72 per share2.18
Masimo Co. stock logo
MASI
Masimo
$2.02B3.80$5.78 per share24.93$25.79 per share5.58
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$358.76M7.62$0.09 per share879.39$4.20 per share19.52

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Integer Holdings Co. stock logo
ITGR
Integer
$90.65M$2.8940.6020.501.806.31%11.48%5.79%2/20/2025 (Estimated)
LivaNova PLC stock logo
LIVN
LivaNova
$17.55M-$0.60N/A16.92N/A-1.37%13.77%7.07%2/19/2025 (Estimated)
Masimo Co. stock logo
MASI
Masimo
$81.50M$1.4797.9733.57N/A3.94%14.07%6.36%11/5/2024 (Confirmed)
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-$25.03M$0.942,049.2544.55N/A0.84%15.98%3.41%2/24/2025 (Estimated)

Latest TMDX, MASI, ITGR, and LIVN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2024N/A
Masimo Co. stock logo
MASI
Masimo
$0.84N/A-$0.84N/AN/AN/A  
10/28/2024Q3 2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$0.29$0.12-$0.17$0.12$115.00 million$108.76 million    
10/24/2024Q3 24
Integer Holdings Co. stock logo
ITGR
Integer
$1.36$1.43+$0.07$1.87$440.59 million$431.42 million      
8/6/2024Q2 2024
Masimo Co. stock logo
MASI
Masimo
$0.77$0.86+$0.09$1.43$493.92 million$496.30 million    
7/31/2024Q2 2024
LivaNova PLC stock logo
LIVN
LivaNova
$0.66$0.81+$0.15$1.32$305.05 million$318.60 million
7/31/2024Q2 2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$0.21$0.35+$0.14$0.35$98.84 million$114.30 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Integer Holdings Co. stock logo
ITGR
Integer
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Masimo Co. stock logo
MASI
Masimo
N/AN/AN/AN/AN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Integer Holdings Co. stock logo
ITGR
Integer
0.73
3.29
1.96
LivaNova PLC stock logo
LIVN
LivaNova
0.49
3.45
2.94
Masimo Co. stock logo
MASI
Masimo
0.55
2.09
1.15
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2.67
9.37
8.48

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Integer Holdings Co. stock logo
ITGR
Integer
99.29%
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Masimo Co. stock logo
MASI
Masimo
85.96%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
99.67%

Insider Ownership

CompanyInsider Ownership
Integer Holdings Co. stock logo
ITGR
Integer
2.00%
LivaNova PLC stock logo
LIVN
LivaNova
0.27%
Masimo Co. stock logo
MASI
Masimo
9.70%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
7.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Integer Holdings Co. stock logo
ITGR
Integer
10,50033.50 million32.86 millionOptionable
LivaNova PLC stock logo
LIVN
LivaNova
2,90054.15 million54.15 millionOptionable
Masimo Co. stock logo
MASI
Masimo
5,20053.20 million48.04 millionOptionable
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
21033.36 million31.02 millionOptionable

MASI, ITGR, TMDX, and LIVN Headlines

Recent News About These Companies

TransMedics Group, Inc. stock logo
FY2024 EPS Forecast for TransMedics Group Lowered by Analyst
TransMedics Group (TMDX) Gets a Buy from TD Cowen
TransMedics Group (TMDX) Receives a Buy from J.P. Morgan
TransMedics: Maintaining A Neutral Stance After A Difficult Q3
TransMedics Group, Inc. stock logo
William Blair Predicts Higher Earnings for TransMedics Group
TransMedics: Every Hero Becomes A Bore At Last

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Integer logo

Integer

NYSE:ITGR
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
LivaNova logo

LivaNova

NASDAQ:LIVN
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Masimo logo

Masimo

NASDAQ:MASI
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
TransMedics Group logo

TransMedics Group

NASDAQ:TMDX
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.